North America DNA Diagnostics Market By Product Type (Instruments, Reagents, Service & Software), Application (Oncology, Infectious Disease Testing, Myogenic Disorder Diagnosis, Clinical Confirmation, Prenatal Diagnosis, Pre-implantation), Technology (PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry), End User

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America DNA Diagnostics Market, by Product Type
1.4.2 North America DNA Diagnostics Market, by Application
1.4.3 North America DNA Diagnostics Market, by Technology
1.4.4 North America DNA Diagnostics Market, by End User
1.4.5 North America DNA Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.3 Opportunities
2.4 North America DNA Diagnostics Market
2.4.1 North America DNA Diagnostics Market - By Country
2.4.2 North America DNA Diagnostics Market - By Product Types
2.4.3 North America DNA Diagnostics Market - By Application
2.4.4 North America DNA Diagnostics Market - By Technology
2.4.5 North America DNA Diagnostics Market - By End Users
Chapter 3. North America DNA Diagnostics Market - By Product Types
3.1 North America DNA Diagnostics Instruments Market - By Country
3.2 North America DNA Diagnostics Reagents Market - By Country
3.3 North America DNA Diagnostics Service & software Market - By Country
Chapter 4. North America DNA Diagnostics Market - By Application
4.1 North America Oncology DNA Diagnostics Market - By Country
4.2 North America Infectious Disease Testing DNA Diagnostics Market - By Country
4.3 North America Myogenic Disorder Diagnosis Market - By Country
4.4 North America Clinical Confirmation Diagnostics Market - By Country
4.5 North America Prenatal Diagnosis Market - By Country
4.6 North America Pre-implantation diagnostics Market - By Country
4.7 North America Others DNA Diagnostics Market - By Country
Chapter 5. North America DNA Diagnostics Market - By Technology
5.1 North America PCR DNA Diagnostics Market - By Country
5.2 North America Microarrays DNA Diagnostics Market - By Country
5.3 North America In situ hybridization DNA Diagnostics Market - By Country
5.4 North America Sequencing Technology DNA Diagnostics Market - By Country
5.5 North America Mass Spectrometry DNA Diagnostics Market - By Country
5.6 North America Other DNA Diagnostics Market - By Country
Chapter 6. North America DNA Diagnostics Market - By End Users
6.1 North America POC DNA Diagnostics Market - By Country
6.2 North America Central Laboratories DNA Diagnostics Market - By Country
6.3 North America Self-Testing DNA Diagnostics Market - By Country
Chapter 7. North America DNA Diagnostics Market - By Country
7.1 U.S DNA Diagnostics Market
7.1.1 U.S DNA Diagnostics Market - By Product Types
7.1.2 U.S DNA Diagnostics Market - By Application
7.1.3 U.S DNA Diagnostics Market - By Technology
7.1.4 U.S DNA Diagnostics Market - By End Users
7.2 Canada DNA Diagnostics Market
7.2.1 Canada DNA Diagnostics Market - By Product Types
7.2.2 Canada DNA Diagnostics Market - By Application
7.2.3 Canada DNA Diagnostics Market - By Technology
7.2.4 Canada DNA Diagnostics Market - By End Users
7.3 Mexico DNA Diagnostics Market
7.3.1 Mexico DNA Diagnostics Market - By Product Types
7.3.2 Mexico DNA Diagnostics Market - By Application
7.3.3 Mexico DNA Diagnostics Market - By Technology
7.3.4 Mexico DNA Diagnostics Market - By End Users
7.4 Rest of North America DNA Diagnostics Market
7.4.1 Rest of North America DNA Diagnostics Market - By Product Types
7.4.2 Rest of North America DNA Diagnostics Market - By Application
7.4.3 Rest of North America DNA Diagnostics Market - By Technology
7.4.4 Rest of North America DNA Diagnostics Market - By End Users
Chapter 8. Company Profile
8.1 Sysmex Corporation.
8.1.1 Company Overview
8.2 Bayer Corporation.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Analysis
8.3 Roche Diagnostics
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Analysis
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development
8.5 Cepheid Inc.
8.5.1 Company Overview
8.6 Hologic Corporation.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Analysis
8.8 Novartis International AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development
8.9 Thermo Fisher Scientific Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Analysis
8.1 Bio-Rad Laboratories.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development